Last reviewed · How we verify
NCT05509673
Lipofilling for Healing of Chronic Wounds
NA trial testing Lipofilling (sublesional fat grafting) in Wound Healing Disorder in 34 participants. Completed in 6 March 2017.
30 November 2016
Quick facts
| Lead sponsor | University of Witten/Herdecke |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | single group |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 34 |
| Start date | 29 June 2011 |
| Primary completion | 30 November 2016 |
| Estimated completion | 6 March 2017 |
Drugs / interventions tested
- Lipofilling (sublesional fat grafting)
Conditions studied
- Wound Healing Disorder — all drugs for Wound Healing Disorder →
Sponsor
University of Witten/Herdecke
Who can join
18 and older, any sex, with Wound Healing Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Chronic wounds remain a therapeutic and financial challenge for physicians and the health care systems. Innovative, cheap and effective treatment methods would be of immense value. The sublesional fat grafting could be such treatment, although the effectiveness and safety have not been assessed in large randomized clinical trials. The aim of this trial was to analyse the effect of adipose tissue on the healing of chronic lower leg wounds. For this purpose, the wounds were surgically cleaned (wound debridement) and then fat was suctioned out from the stomach or thighs and then injected into the edges of the wound and under the wounds. The wounds are covered with a foam dressing that is changed every 3-4 days. There are controls on days 3, 7, 14 and 21 after the intervention and a follow-up examination 2 months after the intervention. The primary objective is the reduction of the wound area 14 days and 2 month after intervention. Secondary objectives are pain level of the wound, bacterial colonialisation of the wound and analysis of the grafted fat tissue (ammount of mesenchymal stem cells)
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Immunomodulatory Mechanisms of Chronic Wound Healing: Translational and Clinical Relevance.
Riaz M, Iqbal MZ, Klar AS, Biedermann T. · · 2025 · cited 1× · PMID 41127507 · DOI 10.1002/mco2.70378
Verify or expand the search:
- PubMed search for NCT05509673
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University of Witten/Herdecke trials
Trials by the same sponsor.
- NCT06866457 — Audio Hypnosis for Reducing Anxiety in Children and Adolescents Undergoing MRI: A Randomized Controlled Trial · NA · recruiting
- NCT06744452 — App-based Stress Management With the mHealth Application "Harmony" · NA · completed
- NCT05557890 — System Constellations in Virtual Reality (VR) · NA · active not recruiting
- NCT05881551 — Pain Assessment Via Force Measurement Using eEgg After Blockade of the Lumbar Facet Joints · NA · completed
- NCT05534282 — Music Therapy With Cancer Affected Children and Their Families · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05509673 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Witten/Herdecke
- Last refreshed: 22 August 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05509673.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing